ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
340K |
6 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
743
|
340K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
37 |
12K |
2 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
37
|
12K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Seeks Trading Halt
|
|
Runaway2020
|
5 |
2.2K |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
5
|
2.2K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
Runaway2020
|
57 |
25K |
0 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
25K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
340K |
6 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
743
|
340K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
340K |
5 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
743
|
340K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
340K |
9 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
743
|
340K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.7K |
1.1M |
9 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Announces GMP Manufacturing Process Developed For IMP761
|
|
Runaway2020
|
11 |
4.4K |
5 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
11
|
4.4K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Results of Meeting
|
|
Runaway2020
|
12 |
5.0K |
0 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
12
|
5.0K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Results of Meeting
|
|
Runaway2020
|
12 |
5.0K |
6 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
12
|
5.0K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
382 |
194K |
7 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
382
|
194K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.7K |
1.1M |
1 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.7K |
1.1M |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.7K |
1.1M |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: INSIGHT-003 triple combination data presented at SITC 2022
|
|
Runaway2020
|
42 |
20K |
3 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
42
|
20K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.7K |
1.1M |
8 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Big week for us good guys...
|
|
Runaway2020
|
9 |
4.8K |
4 |
06/11/22 |
06/11/22 |
ASX - By Stock
|
9
|
4.8K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.7K |
1.1M |
0 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
Runaway2020
|
6 |
3.7K |
10 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
6
|
3.7K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Independent DMC recommends to continue TACTI-003 as planned
|
|
Runaway2020
|
17 |
9.5K |
11 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
17
|
9.5K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board
|
|
Runaway2020
|
35 |
11K |
6 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
35
|
11K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board
|
|
Runaway2020
|
35 |
11K |
3 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
35
|
11K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
Runaway2020
|
51 |
22K |
16 |
11/09/22 |
11/09/22 |
ASX - By Stock
|
51
|
22K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
|
|
Runaway2020
|
51 |
22K |
14 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
51
|
22K
|
14
|
|
ASX - By Stock
|
ECS |
Re:
farm sale
|
|
Runaway2020
|
41 |
9.9K |
1 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
41
|
9.9K
|
1
|
|
ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
Runaway2020
|
2.3K |
524K |
6 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
2.3K
|
524K
|
6
|
|
ASX - By Stock
|
ECS |
Re:
farm sale
|
|
Runaway2020
|
41 |
9.9K |
3 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
41
|
9.9K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Investor Presentation
|
|
Runaway2020
|
44 |
8.6K |
11 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
44
|
8.6K
|
11
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Investor Presentation
|
|
Runaway2020
|
44 |
8.6K |
3 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
44
|
8.6K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Focussed Strategy to Maximise Growth
|
|
Runaway2020
|
75 |
16K |
6 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
75
|
16K
|
6
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Focussed Strategy to Maximise Growth
|
|
Runaway2020
|
75 |
16K |
3 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
75
|
16K
|
3
|
|
ASX - By Stock
|
ECS |
Re:
Ann: Focussed Strategy to Maximise Growth
|
|
Runaway2020
|
75 |
16K |
0 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
75
|
16K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial
|
|
Runaway2020
|
70 |
29K |
2 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
70
|
29K
|
2
|
|
ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
Runaway2020
|
2.3K |
524K |
4 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
2.3K
|
524K
|
4
|
|
ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
Runaway2020
|
2.3K |
524K |
5 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
2.3K
|
524K
|
5
|
|
ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
Runaway2020
|
2.3K |
524K |
2 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
2.3K
|
524K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Leading Oncologists appointed to Clinical Advisory Board
|
|
Runaway2020
|
8 |
4.6K |
6 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
8
|
4.6K
|
6
|
|
ASX - By Stock
|
ECS |
Re:
Hemp Industry News
|
|
Runaway2020
|
116 |
22K |
7 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
116
|
22K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to Present at Healthcare Investor Conferences
|
|
Runaway2020
|
11 |
3.7K |
1 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
11
|
3.7K
|
1
|
|
ASX - By Stock
|
ECS |
Re:
Ann: HY Report - Increasing Sales Drives Revenue Growth
|
|
Runaway2020
|
12 |
3.4K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
12
|
3.4K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to Present at Healthcare Investor Conferences
|
|
Runaway2020
|
11 |
3.7K |
3 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
11
|
3.7K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.7K |
1.1M |
3 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Death of Director Grant Chamberlain
|
|
Runaway2020
|
7 |
3.8K |
3 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
7
|
3.8K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
a current prediction
|
|
Runaway2020
|
128 |
771K |
9 |
05/12/21 |
05/12/21 |
ASX - By Stock
|
128
|
771K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II TACTI-002 trial recruitment successfully completed
|
|
Runaway2020
|
88 |
34K |
4 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
88
|
34K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II TACTI-002 trial recruitment successfully completed
|
|
Runaway2020
|
88 |
34K |
4 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
88
|
34K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Granted Chinese Patent For Eftilagimod Alpha A In Combination With A PD-1 Pathway...
|
|
Runaway2020
|
12 |
4.3K |
5 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
12
|
4.3K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Runaway2020
|
108 |
44K |
8 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
108
|
44K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
|
|
Runaway2020
|
108 |
44K |
2 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
108
|
44K
|
2
|
|